Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00067184 · ClinicalTrials.gov registry record

Fetal Neurobehavioral Development in Methadone Maintained Pregnancies

A clinical trial, sponsored by Johns Hopkins University.

Completed
Registry status
157
Enrollment target

NCT00067184: Completed study, sponsored by Johns Hopkins University.

NCT00067184 is a clinical trial that has completed, run by Johns Hopkins University. The registered enrollment target is 157 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00067184 has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
157 participants
Enrollment target

Study Summary

The purpose of this study is to examine differences in fetal neurobehavior at peak (2 hours after oral dose) vs. trough (2 hours before oral dose) maternal plasma methadone levels.

Interventions

  • DEVICE Toitu 320/325

Trial Details

FieldValue
Enrollment Target 157 participants
Start Date 2002-09
Est. Completion 2010-08
Johns Hopkins University

1,448 total trials

What the finished NCT00067184 record still lists

NCT00067184 is an observational study that tracks outcomes without assigning an intervention. The registered 157 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which Toitu 320/325 is the first listed.

NCT00067184 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00067184 about?

NCT00067184 is a clinical study titled "Fetal Neurobehavioral Development in Methadone Maintained Pregnancies". The purpose of this study is to examine differences in fetal neurobehavior at peak (2 hours after oral dose) vs. trough (2 hours before oral dose) maternal plasma methadone levels.

What is the current status of trial NCT00067184?

This trial is currently completed. The enrollment target is 157 participants. The study started on 2002-09. Estimated completion is 2010-08.

What interventions are being tested in trial NCT00067184?

The interventions under investigation include: Toitu 320/325 (DEVICE).

Who is sponsoring clinical trial NCT00067184?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05052541 · 157 participants · Phase 3

    Safety and Efficacy of Oral Cannabis in Chronic Spine Pain

  • NCT05076942 · 157 participants · Phase 2

    Groningen International Study on Sentinel Nodes in Vulvar Cancer-III

  • NCT06396598 · 157 participants · NA

    Electronic Symptom Monitoring Program for Triggered Palliative Referrals in Patients With Thoracic Cancer

  • NCT06655246 · 157 participants · Phase 1

    A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00067184, the US trial registry maintained by the National Library of Medicine. NCT00067184 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.